JDOC logoJDOC
JPMorgan Healthcare Leaders ETF

3
Loading...
Loading...
News
all
press releases
News Placeholder
MoonLake Immunotherapeutics Stock Draws Wall Street Attention Post Monday’s Plunge: Retail Sees Significant Upside
Needham analyst Serge Belanger lowered the firm's price target on the stock to $20 from $66 but kept a ‘Buy’ rating on the shares.
Stocktwits·17h ago
News Placeholder
Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline
Merck will acquire Verona for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.
Stocktwits·3mo ago

Latest JDOC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.